2023 Q1 Form 10-K Financial Statement

#000168316823001974 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $54.00K $259.0K $486.0K
YoY Change 12.5% 184.62% 38.86%
% of Gross Profit
Depreciation & Amortization $1.000K $1.000K $4.000K
YoY Change 0.0% -50.0% -42.86%
% of Gross Profit
Operating Expenses $54.00K $520.0K $486.0K
YoY Change -78.23% 52.05% -59.06%
Operating Profit -$240.0K -$1.251M
YoY Change -3.23% 5.39%
Interest Expense -$94.00K -$119.0K -$360.0K
YoY Change 22.08% -232.22% 54.51%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$334.0K -$639.0K -$1.548M
YoY Change 10.96% 153.57% 9.01%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$334.0K -$639.0K -$1.548M
YoY Change 10.96% 153.57% 9.01%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 382.6M shares 370.6M shares 361.8M shares
Diluted Shares Outstanding 378.4M shares 361.8M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $107.0K $133.0K $133.0K
YoY Change 72.58% 16.67% 16.67%
Cash & Equivalents $107.0K $133.0K
Short-Term Investments
Other Short-Term Assets $12.00K $19.00K $19.00K
YoY Change 20.0% 35.71% 35.71%
Inventory
Prepaid Expenses $12.00K $19.00K
Receivables
Other Receivables
Total Short-Term Assets $119.0K $152.0K $152.0K
YoY Change 65.28% 18.75% 18.75%
LONG-TERM ASSETS
Property, Plant & Equipment $5.000K $6.000K $6.000K
YoY Change -96.53% -33.33% -96.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $5.000K $6.000K $6.000K
YoY Change -96.53% -96.05% -96.05%
TOTAL ASSETS
Total Short-Term Assets $119.0K $152.0K $152.0K
Total Long-Term Assets $5.000K $6.000K $6.000K
Total Assets $124.0K $158.0K $158.0K
YoY Change -42.59% -43.57% -43.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.021M $1.962M $2.908M
YoY Change 13.22% 13.67% 68.48%
Accrued Expenses $0.00 $0.00
YoY Change -100.0% -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $1.912M $1.940M $1.940M
YoY Change 13.27% 17.36% 17.36%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.909M $4.848M $4.848M
YoY Change 8.2% 11.53% 11.53%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.909M $4.848M $4.848M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $4.909M $4.848M $4.848M
YoY Change 5.91% 8.87% 8.87%
SHAREHOLDERS EQUITY
Retained Earnings -$124.5M -$124.1M
YoY Change 1.26%
Common Stock $384.5K $376.1K
YoY Change 5.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.785M -$4.690M -$4.690M
YoY Change
Total Liabilities & Shareholders Equity $124.0K $158.0K $158.0K
YoY Change -42.59% -43.57% -43.57%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$334.0K -$639.0K -$1.548M
YoY Change 10.96% 153.57% 9.01%
Depreciation, Depletion And Amortization $1.000K $1.000K $4.000K
YoY Change 0.0% -50.0% -42.86%
Cash From Operating Activities -$146.0K -$352.0K -$923.0K
YoY Change 89.61% 69.23% 27.84%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $1.000K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$1.000K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $120.0K 233.0K $943.0K
YoY Change 380.0% -4.51% 20.28%
NET CHANGE
Cash From Operating Activities -$146.0K -352.0K -$923.0K
Cash From Investing Activities 0.000 -$1.000K
Cash From Financing Activities $120.0K 233.0K $943.0K
Net Change In Cash -$26.00K -119.0K $19.00K
YoY Change -50.0% -430.56% -69.35%
FREE CASH FLOW
Cash From Operating Activities -$146.0K -$352.0K -$923.0K
Capital Expenditures $0.00 $1.000K
Free Cash Flow -$352.0K -$924.0K
YoY Change 27.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001103795
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
0-29185
CY2022 dei Entity Registrant Name
EntityRegistrantName
QS ENERGY, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2088326
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
23902 FM 2978
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Tomball
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77375
CY2022 dei City Area Code
CityAreaCode
(775)
CY2022 dei Local Phone Number
LocalPhoneNumber
300-7647
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Public Float
EntityPublicFloat
16914000 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
382557426 shares
CY2022 dei Auditor Firm
AuditorFirmId
572
CY2022 dei Auditor Name
AuditorName
Weinberg & Company, P.A.
CY2022 dei Auditor Location
AuditorLocation
Los Angeles, California
CY2022Q4 us-gaap Cash
Cash
133000 usd
CY2021Q4 us-gaap Cash
Cash
114000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
152000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
128000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
143000 usd
CY2022Q4 us-gaap Assets
Assets
158000 usd
CY2021Q4 us-gaap Assets
Assets
280000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1962000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1726000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
946000 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
930000 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1865000 usd
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1503000 usd
CY2022Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
75000 usd
CY2021Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
150000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
38000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4848000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4347000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
106000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
4848000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
4453000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
376074096 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
376074096 shares
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
59000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
283000 usd
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
355300222 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
355300222 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
376075 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
355301 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
119075925 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
118065699 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124142000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-122594000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4690000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4173000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
158000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
280000 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2021 us-gaap Revenues
Revenues
0 usd
CY2022 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
765000 usd
CY2021 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
837000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
486000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
350000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1251000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-1187000 usd
CY2022 qsep Ppp Loan Debt Forgiveness
PppLoanDebtForgiveness
63000 usd
CY2021 qsep Ppp Loan Debt Forgiveness
PppLoanDebtForgiveness
0 usd
CY2022 us-gaap Interest And Debt Expense
InterestAndDebtExpense
360000 usd
CY2021 us-gaap Interest And Debt Expense
InterestAndDebtExpense
233000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1548000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1420000 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
361790243 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
361790243 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
336041213 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
336041213 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-3507000 usd
CY2021 qsep Cumulative Effect Adjustment For Adoption Of Asu202006 See Note4
CumulativeEffectAdjustmentForAdoptionOfAsu202006SeeNote4
-30000 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
128000 usd
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
261000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
290000 usd
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
40000 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20000 usd
CY2021 qsep Fair Value Of Options And Warrants Issued For Services
FairValueOfOptionsAndWarrantsIssuedForServices
45000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1420000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4173000 usd
CY2022 qsep Common Stock Issued On Exercise Of Warrants
CommonStockIssuedOnExerciseOfWarrants
542000 usd
CY2022 qsep Fair Value Of Options And Warrants Issued For Services
FairValueOfOptionsAndWarrantsIssuedForServices
127000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
20000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1548000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4690000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1548000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1420000 usd
CY2022 qsep Fair Value Of Common Stock Issued For Services
FairValueOfCommonStockIssuedForServices
0 usd
CY2021 qsep Fair Value Of Common Stock Issued For Services
FairValueOfCommonStockIssuedForServices
40000 usd
CY2022 qsep Fair Value Of Common Stock Issued As Compensation
FairValueOfCommonStockIssuedAsCompensation
0 usd
CY2021 qsep Fair Value Of Common Stock Issued As Compensation
FairValueOfCommonStockIssuedAsCompensation
20000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
127000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
45000 usd
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
149000 usd
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
59000 usd
CY2022 qsep Accrued Interest Expense
AccruedInterestExpense
162000 usd
CY2021 qsep Accrued Interest Expense
AccruedInterestExpense
124000 usd
CY2022 qsep Decrease In Operating Lease Right Of Use Asset
DecreaseInOperatingLeaseRightOfUseAsset
143000 usd
CY2021 qsep Decrease In Operating Lease Right Of Use Asset
DecreaseInOperatingLeaseRightOfUseAsset
22000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4000 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7000 usd
CY2022 qsep Gain On Partial Forgiveness Of Ppp Notes Payable
GainOnPartialForgivenessOfPppNotesPayable
63000 usd
CY2021 qsep Gain On Partial Forgiveness Of Ppp Notes Payable
GainOnPartialForgivenessOfPppNotesPayable
-0 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5000 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-32000 usd
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
16000 usd
CY2021 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
230000 usd
CY2022 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
236000 usd
CY2021 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
235000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
0 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-95000 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-144000 usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-21000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-923000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-722000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
128000 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
393000 usd
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
658000 usd
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
562000 usd
CY2021 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
0 usd
CY2022 qsep Principal Payment On Ppp Loan Payable
PrincipalPaymentOnPppLoanPayable
12000 usd
CY2021 qsep Principal Payment On Ppp Loan Payable
PrincipalPaymentOnPppLoanPayable
2000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
943000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
784000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
19000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
62000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
133000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1600 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1600 usd
CY2022 qsep Adjustment For Adoption Of Asu202006
AdjustmentForAdoptionOfAsu202006
0 usd
CY2021 qsep Adjustment For Adoption Of Asu202006
AdjustmentForAdoptionOfAsu202006
30000 usd
CY2022 qsep Recording Of Operating Lease Right Of Use Asset And Liability
RecordingOfOperatingLeaseRightOfUseAssetAndLiability
0 usd
CY2021 qsep Recording Of Operating Lease Right Of Use Asset And Liability
RecordingOfOperatingLeaseRightOfUseAssetAndLiability
165000 usd
CY2022 qsep Conversion Of Convertible Notes To Common Stock Net
ConversionOfConvertibleNotesToCommonStockNet
59000 usd
CY2021 qsep Conversion Of Convertible Notes To Common Stock Net
ConversionOfConvertibleNotesToCommonStockNet
261000 usd
CY2022 qsep Value Of Warrants And Beneficial Conversion Feature Associated With Issued Convertible Notes
ValueOfWarrantsAndBeneficialConversionFeatureAssociatedWithIssuedConvertibleNotes
283000 usd
CY2021 qsep Value Of Warrants And Beneficial Conversion Feature Associated With Issued Convertible Notes
ValueOfWarrantsAndBeneficialConversionFeatureAssociatedWithIssuedConvertibleNotes
290000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1548000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-923000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4690000 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
1730000 usd
CY2022Q4 us-gaap Cash
Cash
133000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
101000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
96000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
92000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zPND7nuwo4Ba" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_869_zPDWuyQsf8f1">Use of Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates include those related to assumptions used in impairment analysis for property and equipment, assumption used in valuing the issuance of convertible notes and the corresponding debt discount, assumptions used in valuing equity instruments issued for services, and valuation allowance for deferred tax assets, among others. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><b> </b></p>
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9000 usd
CY2022 us-gaap Depreciation
Depreciation
4000 usd
CY2021 us-gaap Depreciation
Depreciation
7000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
486000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
350000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
102000 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1393000 usd
CY2021Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1137000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
612000 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
452000 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
2005000 usd
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1589000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
140000 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
86000 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1865000 usd
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1503000 usd
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
59000 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
149000 usd
CY2021Q1 qsep Decrease In Retained Earnings Accumulated Deficit
DecreaseInRetainedEarningsAccumulatedDeficit
30000 usd
CY2022 qsep Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
63000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
486000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
350000 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2021 us-gaap Revenues
Revenues
0 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-167000 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-150000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
167000 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
150000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
13124000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
13008000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
27000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
9000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
35000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
18000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13132000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13017000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
62000000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.21 pure
CY2022Q4 qsep Accrued Expenses Related Parties
AccruedExpensesRelatedParties
6000 usd
CY2021Q4 qsep Accrued Expenses Related Parties
AccruedExpensesRelatedParties
0 usd
CY2022Q4 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
384500 usd
CY2022Q4 us-gaap Other Commitment Due In Second Year
OtherCommitmentDueInSecondYear
187500 usd
CY2022Q4 us-gaap Other Commitment Due In Third Year
OtherCommitmentDueInThirdYear
187500 usd
CY2022Q4 us-gaap Other Commitment Due In Fourth Year
OtherCommitmentDueInFourthYear
187500 usd
CY2022Q4 us-gaap Other Commitment Due In Fifth Year
OtherCommitmentDueInFifthYear
187500 usd
CY2022Q4 us-gaap Other Commitment
OtherCommitment
1134500 usd
CY2022Q4 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
197000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
qsep-20221231_def.xml Edgar Link unprocessable
qsep-20221231_pre.xml Edgar Link unprocessable
0001683168-23-001974-index-headers.html Edgar Link pending
0001683168-23-001974-index.html Edgar Link pending
0001683168-23-001974.txt Edgar Link pending
qsep-20221231_cal.xml Edgar Link unprocessable
0001683168-23-001974-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qsenergy_ex3101.htm Edgar Link pending
qsenergy_ex3102.htm Edgar Link pending
qsenergy_ex3201.htm Edgar Link pending
qsenergy_i10k-123122.htm Edgar Link pending
qsep-20221231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
qsenergy_i10k-123122_htm.xml Edgar Link completed
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
qsep-20221231_lab.xml Edgar Link unprocessable